Home > Healthcare > Medical Devices > Diagnostic Devices > Specimen Validity Testing Market

Specimen Validity Testing Market Share

Report ID: GMI5863
Published Date: May 2023
Report Format: PDF

Download Free Sample

Specimen Validity Testing Market Share

Some of the major players operating in the specimen validity testing market are

Abbott Laboratories
ACM Global Laboratories
Alfa Scientific Designs, Inc.
American Bio Medica Corporation
Danaher Corporation
Express Diagnostics
GenomeWeb LLC.
Genway Biotech, Inc.
LabCorp
Premier Biotech, Inc.
Quest Diagnostics Incorporated.
Sciteck, Inc.
SureHire
Thermo Fisher Scientific Inc.

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for specimen validity testing was around USD 2.4 billion in 2022 and will reach over USD 4.7 billion by the end of 2032.

Specimen validity testing industry share from the drug screening laboratories segment will record a 6.5% CAGR from 2023-2032 on account of the wide-range availability of advanced detection & screening equipment and services across these labs.

North America specimen validity testing market size will surpass USD 1.9 billion by 2032 due to factors like presence of key market players and an increase in the number of illicit drug use.

Abbott Laboratories, Alfa Scientific Designs, Inc., ACM Global Laboratories, Danaher Corporation, Express Diagnostics, American Bio Medica Corporation, GenomeWeb LLC., LabCorp, Premier Biotech, Inc., Quest Diagnostics Incorporated., and Sciteck, Inc.